5) Therapeutics
Abstract
Cutaneous and Ocular: Focuses on minimizing injuries to dermal and ocular tissues resulting from exposure to chemical warfare agents (CWA). This work is designed to support eventual Food and Drug Administration (FDA) licensure of new compounds or new indications for licensed products for use in the treatment of chemical warfare casualties.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2012
- Source ID
- f93da3782db1e84a33b3deb4135f1bbd